Scientific Reports · 2019 · 78 citations · 46 references
Life SciencesNeurobiologyNeuroscienceCell AdhesionInflammationNeuroimmunologyAlzheimer DiseaseImmune Cell TraffickingLeukocyte AdhesionLeukocyte TraffickingNeurodegenerative DiseasesNeuroinflammationAlzheimer Disease DementiaCerebral VesselsEndothelial-leukocyte InteractionsIntravital MicroscopyLeukocyte InteractionsNeuroinflammation In Alzheimer DiseaseTau HyperphosphorylationTherapeutic Targeting Of Amyloid
Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline associated with the deposition of amyloid-β (Aβ) plaques, hyperphosphorylation of tau protein, and neuronal loss. Vascular inflammation and leukocyte trafficking may contribute to AD pathogenesis, and a better understanding of these inflammation mechanisms could therefore facilitate the development of new AD therapies. Here we show that T cells extravasate in the proximity of cerebral VCAM-1 + vessels in 3xTg-AD transgenic mice, which develop both Aβ and tau pathologies. The counter-ligand of VCAM-1 – α4β1 integrin, also known as very late antigen-4 (VLA-4) – was more abundant on circulating CD4 + T cells and was also expressed by a significant proportion of blood CD8 + T cells and neutrophils in AD mice. Intravital microscopy of the brain microcirculation revealed that α4 integrins control leukocyte–endothelial interactions in AD mice. Therapeutic targeting of VLA-4 using antibodies that specifically block α4 integrins improved the memory of 3xTg-AD mice compared to an isotype control. These antibodies also reduced neuropathological hallmarks of AD, including microgliosis, Aβ load and tau hyperphosphorylation. Our results demonstrate that α4 integrin-dependent leukocyte trafficking promotes cognitive impairment and AD neuropathology, suggesting that the blockade of α4 integrins may offer a new therapeutic strategy in AD.
46
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
Salvatore Oddo, Antonella Caccamo, Jason D. Shepherd et al. · Neuron · 2003 · 4.1K citations · Full text
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Ted Yednock, Catherine Cannon, Lawrence C. Fritz et al. · Nature · 1992 · 1.7K citations
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text